EveroliMus iMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Everolimus-13C2,D4 is used in the evaluation of LC-MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard. An Isotopically labelled analog of Everolimus (E945400), a derivative of Rapamycin, that also inhibits cytokine-mediated lymphocyte proliferation.

EveroliMus iMpurity Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EveroliMus iMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-83725681-603		China	4496	50
Shenzhen DaerSen Science and Technology Co., Ltd.	0755-84551027		China	220	58
Nanjing Chempioneer Pharmaceutical Co., Ltd.	18068075658	sales@chempioneer.com	China	1811	58
Pharmacodia (Beijing) Co.,Ltd	+86-400-851-9921	sales@pharmacodia.com	China	2317	55
Roark Standards	0755-83552066 15986688328	service@roarkstandards.com	China	1442	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233746@qq.com	China	9919	12
Jinan blalong chemical co. LTD	2710913286@.com	1513643261@qq.com	China	14246	58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD	0755-0755-0755-83725350 13380397412	3001280422@qq.com	China	10005	58

---

• Everolimus IMP
• (Everolimus-13C2-d4
• Everolimus Impurity 23(Everolimus-13C2-d4)
• Everolimus Impurity 23
• Everolimus-13C2,D4 (~90%) DISCONTINUED. Please see E945402.
• Everolimus-13C2,d4 (Everolimus Impurity)
• 1661009-29-5